Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
The PCI FY23 Year in Review is Now Available!
#1
Penn Ranked #1 Nationally for Licensing Income (AUTM)
Over $1.2 Billion
Raised or Received by Penn-affiliated Startups
>1 Billion
Individuals and Patients Benefiting from Penn Discoveries
Over 100 startups
Spun Out Over the Past 5 Years
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Meet Our TeamAvailable Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologiesPhiladelphia—The Penn Center for Innovation (PCI) has announced two key appointments to support the next phase of its comprehensive innovation and commercialization plan. Building on his notable success leading the creation and remarkable growth of PCI over the last decade, John Swartley, PhD, has been promoted to Penn’s Chief Innovation Officer (CIO), a new position created by the University to further expand and implement a University-wide innovation agenda in close partnership with PCI and other critical stakeholders at Penn. Benjamin Dibling, PhD, most recently PCI’s Deputy Managing Director, has been promoted to Associate Vice Provost for Research and Managing Director of PCI.
Read the full story hereDownload Our List of Penn Startups Raising Money
Learn about which Penn startup companies are raising money in 2024 with this comprehensive list. With companies in connected health, digital health, diagnostics, therapeutics, and medical devices, Penn offers a wide range of rapidly emerging companies at all investment levels.
If you are interested in connecting about these startups, please email Laurie Actman (lactman@upenn.edu).
Download and view the complete listWatch the Recording of our program “Innovation @ Penn: The Future of Neuroscience”
In parallel with the 2024 JP Morgan Healthcare Conference, PCI hosted the Innovation @ Penn program “The Future of Neuroscience” in San Francisco on January 8, 2024.
The event was introduced by Benjamin Dibling, PhD, Managing Director, PCI, and Jim Bowen, PhD, Executive Director, Corporate Alliances, PCI, served as the moderator.
Our panel featured an exciting line-up of experts in the field of brain science and neurobiology, including leading luminaries:
Brian Litt, MD, Perelman Professor of Neurology at Penn Medicine and Director, Penn Health-Tech
Michael Kahana, PhD, Penn SAS Professor of Psychology at the University of Pennsylvania and Co-Founder & Chairman of the Scientific Advisory Board for Nia Therapeutics
Anna Wexler, PhD, Assistant Professor of Medical Ethics and Health Policy at the University of Pennsylvania.
The panel offered an in-depth discussion about what is next for neuroscience at Penn and beyond, including memory, neuro-ethics, the relationship between AI and neuroscience, and the latest neuroscience research and technology.
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
Discover cutting-edge CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.